Feasibility of Ultra-sound Guided Radiofrequency Ablation in the Management of Head and Neck Neoplasia.

Not Applicable

Withdrawn

• Conditions: Head and Neck Neoplasia

• Registration Number: NCT00381225
• Lead Sponsor: Johns Hopkins University

Brief Summary

To study the feasibility of Radiofrequency ablation (RFA) via ultrasound guidance in the management of head and neck neoplasia.

Detailed Description

The study evaluates the feasibility of radio-frequency ablation in the management of head and neck neoplasia.

Study Timeline

• Study First Submitted: 2006-09-26
• Study First Submitted QC: 2006-09-26
• Study First Posted: 2006-09-27
• Study Start: 2006-11
• Primary Completion: 2008-03-18
• Study Completion: 2008-03-18
• Status Verified: 2017-09
• Last Update Submitted: 2017-09-05
• Last Update Posted: 2017-09-08

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Patients with head and neck neoplasia.

Exclusion Criteria

• When the patient does not meet the inclusion criteria.
• When the patient has a contra-indication of surgery or anesthesia.
• If the patient refuses involvement in the study.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Technical success	Length of the procedure, up to 1 hour	Technical success is defined as the ability to successfully enter the thyroid nodule via ultrasound guidance and apply the RFA. Assessed via surgeon self report

Trial Locations

Locations (1)

Johns Hopkins University School of Medicine, Department of Otolaryngology-Head and Neck Surgery; 🇺🇸 Baltimore, Maryland, United States